Mondelez International, Inc. (MDLZ) › Analysis

Mondelez International, Inc. (MDLZ) analysis, February 27, 2026

Published February 27, 2026 · MDLZ chart, levels and live analysis

Key Updates

Mondelez shares surged 2.20% to $61.30 since the February 23 report, breaking back above the critical $61 support level and extending YTD gains to 13.88%. The recovery is supported by positive industry dynamics, with the global packaged food market projected to grow from $6.61 trillion in 2026 to $8.15 trillion by 2031, and Morningstar analysts reaffirming MDLZ as undervalued with an 18% discount to fair value. However, the investment thesis faces near-term headwinds as weak U.S. consumer demand persists, cocoa cost pressures remain locked in for 2026, and PepsiCo's aggressive 15% price cuts on major snack brands intensify competitive pressures in the discretionary snacks category.

Current Trend

MDLZ demonstrates strong YTD momentum with 13.88% gains, significantly outperforming the broader market and recovering from the mid-February selloff that had pushed shares below $61. The stock has posted positive returns across all short-term periods: +2.27% (1-day), +4.25% (5-day), and +6.18% (1-month), indicating strengthening buyer conviction. The 6-month performance of -0.74% reflects the significant February 4 earnings selloff when shares dropped 4.8% after-hours, but recent price action suggests this correction has been absorbed. The stock is now testing resistance at the $61.30 level, with the February recovery establishing a higher low pattern around $58.78. Trading at 17 times 2026 earnings despite elevated cocoa costs positions MDLZ competitively within the consumer staples sector.

Investment Thesis

The investment thesis centers on MDLZ's superior emerging market exposure (40% of sales versus 25-30% for peers) positioning the company to capitalize on the $6.61 trillion to $8.15 trillion global packaged food market expansion through 2031, with Asia-Pacific representing 33% of the market. The company targets mid-single-digit growth in emerging markets and projects 10% earnings growth from 2026 to 2029, supported by strategic initiatives including premium product rollouts (sugar-free Oreos, high-protein Clif Builders bars), value channel expansion, and increased advertising spend. The 3.3% dividend yield provides downside protection while management navigates near-term cocoa cost headwinds. Structural advantages include locked-in 2026 cocoa supplies positioning MDLZ to benefit from cocoa price deflation in 2027, diversified geographic exposure reducing regional demand volatility, and brand strength in categories with high household penetration. The valuation at 18% below fair value per Morningstar analysis offers attractive entry points for long-term investors willing to look through 2026's muted growth outlook of flat to 2% organic revenue growth.

Thesis Status

The investment thesis remains intact but faces heightened near-term execution risk. The core structural advantages—emerging market exposure, brand portfolio strength, and long-term market growth trajectory—are validated by the Mordor Intelligence market forecast and Morningstar's undervaluation assessment. However, three developments since the last report require monitoring: (1) PepsiCo's aggressive 15% price cuts on Lay's, Doritos, Cheetos, and Tostitos directly target MDLZ's biscuit and snack categories where the company already reported weakness, potentially forcing competitive pricing responses that could compress margins; (2) Ferrero's $3.1 billion WK Kellogg acquisition establishes the world's third-largest sweet packaged foods maker with increased scale and cross-promotional capabilities between Nutella, Kinder, and cereal brands, intensifying competition in the U.S. market; (3) Consumer confidence remains near historic lows with shoppers prioritizing essential foods over discretionary snacks, validating management's assessment that economic anxiety will persist through 2026. The 2027 cocoa cost relief remains a critical thesis component, but the 12-month wait requires investors to endure margin pressure and potentially sluggish volume recovery. The thesis shifts from near-term growth to a value-oriented, dividend-supported holding period until structural improvements materialize in 2027.

Key Drivers

The primary near-term driver is competitive intensity in the snacks category, with PepsiCo announcing up to 15% price cuts on major brands targeting price-sensitive consumers. This directly pressures MDLZ's U.S. biscuit business, which already experienced volume declines of 4.8 percentage points in Q4 as consumers prioritize essential foods over discretionary snacks. The second driver is cocoa cost dynamics, where prices have plummeted 30% in the past month but MDLZ's hedged positions at elevated rates prevent immediate margin relief, with benefits delayed until 2027. The third driver is industry consolidation, as Ferrero's acquisition of WK Kellogg creates a more formidable competitor with 24% U.S. revenue exposure and cross-brand innovation capabilities. The fourth driver is long-term market expansion, with Asia-Pacific leading 33% market share in a sector growing to $8.15 trillion by 2031, directly benefiting MDLZ's 40% emerging market exposure. The fifth driver is valuation support, with Morningstar assigning a 5-star rating and 18% discount to fair value, providing institutional buying interest at current levels.

Technical Analysis

MDLZ has completed a technical reversal from the February 20 low of $58.78, reclaiming the $61 psychological support level that served as resistance during the February 17-23 period. The current price of $61.30 represents a 4.29% recovery from the recent low and establishes a higher low pattern, suggesting accumulation following the earnings-driven selloff. The 5-day gain of 4.25% and 1-month gain of 6.18% demonstrate strengthening momentum, while the YTD performance of 13.88% positions the stock well above its 6-month performance of -0.74%, indicating a sharp Q1 2026 rally. Key resistance levels lie at $62-63, representing the pre-earnings range before the February 4 selloff. Support is now established at $60-61, with the $58.78 level serving as secondary support. Volume patterns during the recent recovery suggest institutional participation rather than retail-driven momentum. The stock's ability to hold above $61 despite negative news flow regarding consumer weakness and competitive pricing indicates underlying bid support, likely from value-oriented investors responding to the Morningstar undervaluation thesis. The technical setup favors consolidation in the $61-63 range near-term, with a breakout above $63 requiring positive catalysts such as improved consumer confidence data or accelerated cocoa price declines.

Bull Case

Bear Case

Get a message when the MDLZ picture changes — the agent team watches the levels and the news for you.Create a free account

More MDLZ analyses